Spring Bank Pharmaceuticals Inc
01748 Hopkinton, Ηνωμένες Πολιτείες
Spring Bank Pharmaceuticals Inc Company Information
Γενικές πληροφορίες
Spring Bank Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using our proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. SMNH compounds are small segments of nucleic acids that the company designs to selectively target and modulate the activity of specific proteins implicated in various disease states. Spring Bank is developing its most advanced SMNH product candidate, inarigivir soproxil (formerly referred to as SB 9200), for the treatment of viral diseases, including hepatitis B virus (HBV), and other SMNH product candidates, including SB 11285, the company's lead immunotherapeutic agent for the treatment of selected cancers through the activation of the STimulator of Interferon Genes, or STING, pathway.
86 South Street Hopkinton
- Ώρες Λειτουργείας
-
Δευτέρα:08:30 - 17:00Τρίτη:08:30 - 17:00Τετάρτη:08:30 - 17:00Πέμπτη:08:30 - 17:00Παρασκευή:08:30 - 17:00
- Δωμάτια
- Η εταιρεία διαθέτει χώρο στάθμευσης.
- Αριθμός τηλεφώνου
- +1508-473-5993
- Linki
- Λογαριασμοί κοινωνικών δικτύων
- Λέξεις-κλειδιά
- φαρμακευτική εταιρεία
Spring Bank Pharmaceuticals Inc Reviews & Ratings
How do you rate this company?
Are you the owner of this company? If so, do not lose the opportunity to update your company's profile, add products, offers and higher position in search engines.